188 related articles for article (PubMed ID: 32458023)
1. Ubiquitin chromatin remodelling after DNA damage is associated with the expression of key cancer genes and pathways.
Cole AJ; Dickson KA; Liddle C; Stirzaker C; Shah JS; Clifton-Bligh R; Marsh DJ
Cell Mol Life Sci; 2021 Feb; 78(3):1011-1027. PubMed ID: 32458023
[TBL] [Abstract][Full Text] [Related]
2. The RING finger domain E3 ubiquitin ligases BRCA1 and the RNF20/RNF40 complex in global loss of the chromatin mark histone H2B monoubiquitination (H2Bub1) in cell line models and primary high-grade serous ovarian cancer.
Dickson KA; Cole AJ; Gill AJ; Clarkson A; Gard GB; Chou A; Kennedy CJ; Henderson BR; ; Fereday S; Traficante N; Alsop K; Bowtell DD; deFazio A; Clifton-Bligh R; Marsh DJ
Hum Mol Genet; 2016 Dec; 25(24):5460-5471. PubMed ID: 27798111
[TBL] [Abstract][Full Text] [Related]
3. Histone H2B monoubiquitination: roles to play in human malignancy.
Cole AJ; Clifton-Bligh R; Marsh DJ
Endocr Relat Cancer; 2015 Feb; 22(1):T19-33. PubMed ID: 24891457
[TBL] [Abstract][Full Text] [Related]
4. p53-mediated control of gene expression via mRNA translation during Endoplasmic Reticulum stress.
López I; Tournillon AS; Nylander K; Fåhraeus R
Cell Cycle; 2015; 14(21):3373-8. PubMed ID: 26397130
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of LRRC8A protects human ovarian and alveolar carcinoma cells against Cisplatin-induced expression of p53, MDM2, p21Waf1/Cip1, and Caspase-9/-3 activation.
Sørensen BH; Nielsen D; Thorsteinsdottir UA; Hoffmann EK; Lambert IH
Am J Physiol Cell Physiol; 2016 Jun; 310(11):C857-73. PubMed ID: 26984736
[TBL] [Abstract][Full Text] [Related]
6. Role of H2B mono-ubiquitination in the initiation and progression of cancer.
Zhou S; Cai Y; Liu X; Jin L; Wang X; Ma W; Zhang T
Bull Cancer; 2021 Apr; 108(4):385-398. PubMed ID: 33685627
[TBL] [Abstract][Full Text] [Related]
7. The kinetics of p53-binding and histone acetylation at target promoters do not strictly correlate with gene expression after UV damage.
Magrini R; Russo D; Fronza G; Inga A; Menichini P
J Cell Biochem; 2007 Apr; 100(5):1276-87. PubMed ID: 17063487
[TBL] [Abstract][Full Text] [Related]
8. Mouse double minute 2 associates with chromatin in the presence of p53 and is released to facilitate activation of transcription.
White DE; Talbott KE; Arva NC; Bargonetti J
Cancer Res; 2006 Apr; 66(7):3463-70. PubMed ID: 16585169
[TBL] [Abstract][Full Text] [Related]
9. Regulation of p53 target gene expression by cisplatin-induced extracellular signal-regulated kinase.
DeHaan RD; Yazlovitskaya EM; Persons DL
Cancer Chemother Pharmacol; 2001 Nov; 48(5):383-8. PubMed ID: 11761456
[TBL] [Abstract][Full Text] [Related]
10. Histone H2B monoubiquitination regulates heart development via epigenetic control of cilia motility.
Robson A; Makova SZ; Barish S; Zaidi S; Mehta S; Drozd J; Jin SC; Gelb BD; Seidman CE; Chung WK; Lifton RP; Khokha MK; Brueckner M
Proc Natl Acad Sci U S A; 2019 Jul; 116(28):14049-14054. PubMed ID: 31235600
[TBL] [Abstract][Full Text] [Related]
11. Cisplatin resistance in non-small cell lung cancer cells is associated with an abrogation of cisplatin-induced G2/M cell cycle arrest.
Sarin N; Engel F; Kalayda GV; Mannewitz M; Cinatl J; Rothweiler F; Michaelis M; Saafan H; Ritter CA; Jaehde U; Frötschl R
PLoS One; 2017; 12(7):e0181081. PubMed ID: 28746345
[TBL] [Abstract][Full Text] [Related]
12. A novel apoptotic mechanism of genetically engineered adenovirus-mediated tumour-specific p53 overexpression through E1A-dependent p21 and MDM2 suppression.
Yamasaki Y; Tazawa H; Hashimoto Y; Kojima T; Kuroda S; Yano S; Yoshida R; Uno F; Mizuguchi H; Ohtsuru A; Urata Y; Kagawa S; Fujiwara T
Eur J Cancer; 2012 Sep; 48(14):2282-91. PubMed ID: 22244827
[TBL] [Abstract][Full Text] [Related]
13. KLF11 promotes the proliferation of breast cancer cells by inhibiting p53-MDM2 signaling.
Hou ZH; Tao M; Dong J; Qiu HM; Li F; Bai XY
Cell Signal; 2024 Aug; 120():111238. PubMed ID: 38810862
[TBL] [Abstract][Full Text] [Related]
14. Monoubiquitination of Histone H2B Blocks Eviction of Histone Variant H2A.Z from Inducible Enhancers.
Segala G; Bennesch MA; Pandey DP; Hulo N; Picard D
Mol Cell; 2016 Oct; 64(2):334-346. PubMed ID: 27692985
[TBL] [Abstract][Full Text] [Related]
15. Regulation of the MDM2-p53 pathway by the ubiquitin ligase HERC2.
García-Cano J; Sánchez-Tena S; Sala-Gaston J; Figueras A; Viñals F; Bartrons R; Ventura F; Rosa JL
Mol Oncol; 2020 Jan; 14(1):69-86. PubMed ID: 31665549
[TBL] [Abstract][Full Text] [Related]
16. Histone Monoubiquitination in Chromatin Remodelling: Focus on the Histone H2B Interactome and Cancer.
Marsh DJ; Ma Y; Dickson KA
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33233707
[TBL] [Abstract][Full Text] [Related]
17. Loss of H2B monoubiquitination is associated with poor-differentiation and enhanced malignancy of lung adenocarcinoma.
Zhang K; Wang J; Tong TR; Wu X; Nelson R; Yuan YC; Reno T; Liu Z; Yun X; Kim JY; Salgia R; Raz DJ
Int J Cancer; 2017 Aug; 141(4):766-777. PubMed ID: 28481029
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic regulation of ferroptosis by H2B monoubiquitination and p53.
Wang Y; Yang L; Zhang X; Cui W; Liu Y; Sun QR; He Q; Zhao S; Zhang GA; Wang Y; Chen S
EMBO Rep; 2019 Jul; 20(7):e47563. PubMed ID: 31267712
[TBL] [Abstract][Full Text] [Related]
19. Differential response between the p53 ubiquitin-protein ligases Pirh2 and MdM2 following DNA damage in human cancer cells.
Duan W; Gao L; Wu X; Zhang Y; Otterson GA; Villalona-Calero MA
Exp Cell Res; 2006 Oct; 312(17):3370-8. PubMed ID: 16934800
[TBL] [Abstract][Full Text] [Related]
20. Status of p53 phosphorylation and function in sensitive and resistant human cancer models exposed to platinum-based DNA damaging agents.
Mujoo K; Watanabe M; Nakamura J; Khokhar AR; Siddik ZH
J Cancer Res Clin Oncol; 2003 Dec; 129(12):709-18. PubMed ID: 14513366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
